Connection

Charles Bennett to Aged

This is a "connection" page, showing publications Charles Bennett has written about Aged.
Connection Strength

1.838
  1. The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. Oncologist. 2021 08; 26(8):e1418-e1426.
    View in: PubMed
    Score: 0.061
  2. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
    View in: PubMed
    Score: 0.058
  3. Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 05; 8(5):2233-2240.
    View in: PubMed
    Score: 0.053
  4. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening? Clin Genitourin Cancer. 2017 12; 15(6):e977-e985.
    View in: PubMed
    Score: 0.047
  5. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.
    View in: PubMed
    Score: 0.046
  6. Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
    View in: PubMed
    Score: 0.045
  7. Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system. Expert Opin Drug Saf. 2016 Aug; 15(8):1003-11.
    View in: PubMed
    Score: 0.044
  8. Time course and predictors of use of erectile dysfunction treatment in a Veterans Affairs medical center. Int J Impot Res. 2016 Sep; 28(5):167-71.
    View in: PubMed
    Score: 0.044
  9. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
    View in: PubMed
    Score: 0.042
  10. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system. Expert Opin Drug Saf. 2015; 14(11):1653-60.
    View in: PubMed
    Score: 0.042
  11. Screening for viral hepatitis prior to rituximab chemotherapy. Ann Hematol. 2016 Jan; 95(1):27-33.
    View in: PubMed
    Score: 0.042
  12. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014 Aug 15; 120(16):2464-71.
    View in: PubMed
    Score: 0.038
  13. Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. 2013 Apr; 131(4):499-506.
    View in: PubMed
    Score: 0.035
  14. Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol. 2010 May 20; 28(15):2571-6.
    View in: PubMed
    Score: 0.029
  15. Metastasis of genitourinary tumors to the head and neck region. Eur Arch Otorhinolaryngol. 2010 Feb; 267(2):273-9.
    View in: PubMed
    Score: 0.027
  16. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14; 113(20):4834-40.
    View in: PubMed
    Score: 0.026
  17. Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. 2009 Feb; 47(2):176-83.
    View in: PubMed
    Score: 0.026
  18. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008 Sep 15; 113(6):1446-52.
    View in: PubMed
    Score: 0.026
  19. Late-onset hereditary axonal neuropathies. Neurology. 2008 Jul 01; 71(1):14-20.
    View in: PubMed
    Score: 0.025
  20. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
    View in: PubMed
    Score: 0.024
  21. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. 2007 Aug; 12(8):1019-26.
    View in: PubMed
    Score: 0.024
  22. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. 2007 Jul; 8(3):273-81.
    View in: PubMed
    Score: 0.024
  23. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim.
    View in: PubMed
    Score: 0.023
  24. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007 Apr; 12(4):478-83.
    View in: PubMed
    Score: 0.023
  25. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. 2007 Feb; 131(2):489-96.
    View in: PubMed
    Score: 0.023
  26. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006 Jul; 68(1):89-93.
    View in: PubMed
    Score: 0.022
  27. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. 2005 Dec 01; 23(34):8877-83.
    View in: PubMed
    Score: 0.021
  28. Pure red-cell aplasia and epoetin therapy. N Engl J Med. 2004 Sep 30; 351(14):1403-8.
    View in: PubMed
    Score: 0.019
  29. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004 Sep 01; 22(17):3524-30.
    View in: PubMed
    Score: 0.019
  30. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. 2004 Jul 01; 22(13):2617-22.
    View in: PubMed
    Score: 0.019
  31. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004 Jun; 3(1):31-7.
    View in: PubMed
    Score: 0.019
  32. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004 May-Jun; 2(3):271-8.
    View in: PubMed
    Score: 0.019
  33. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. 2004 Apr; 93(1):164-9.
    View in: PubMed
    Score: 0.019
  34. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
    View in: PubMed
    Score: 0.019
  35. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
    View in: PubMed
    Score: 0.018
  36. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003 Dec 01; 37(11):1549-55.
    View in: PubMed
    Score: 0.018
  37. Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. 2003 Oct 15; 48(Suppl):S71-4.
    View in: PubMed
    Score: 0.018
  38. Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. 2003; 20(7):479-83.
    View in: PubMed
    Score: 0.017
  39. Medicare Spending on Drugs With Accelerated Approval. Ann Intern Med. 2022 07; 175(7):938-944.
    View in: PubMed
    Score: 0.017
  40. Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
    View in: PubMed
    Score: 0.015
  41. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
    View in: PubMed
    Score: 0.015
  42. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000 Jun 15; 342(24):1773-7.
    View in: PubMed
    Score: 0.014
  43. Operation Safe Haven: an evaluation of health surveillance and monitoring in an acute setting. Commun Dis Intell. 2000 Feb 17; 24(2):21-6.
    View in: PubMed
    Score: 0.014
  44. Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis. Cancer Causes Control. 2020 Mar; 31(3):209-220.
    View in: PubMed
    Score: 0.014
  45. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Ann Oncol. 1999 Nov; 10(11):1355-9.
    View in: PubMed
    Score: 0.014
  46. Preparing for refugee crises in Australia: Kosovar health surveillance. Commun Dis Intell. 1999 Oct 28; 23(11):305.
    View in: PubMed
    Score: 0.014
  47. Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res. 1999 Aug; 8(5):461-70.
    View in: PubMed
    Score: 0.014
  48. Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg. 1999 Jun; 188(6):604-22.
    View in: PubMed
    Score: 0.013
  49. A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res. 1999 May; 8(3):171-80.
    View in: PubMed
    Score: 0.013
  50. Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann Oncol. 1999 Feb; 10(2):177-82.
    View in: PubMed
    Score: 0.013
  51. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct; 37(10):2099-2108.
    View in: PubMed
    Score: 0.013
  52. Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest. 1999; 17(8):559-65.
    View in: PubMed
    Score: 0.013
  53. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol. 1998 Nov; 160(5):1765-9.
    View in: PubMed
    Score: 0.013
  54. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998 Sep; 16(9):3101-4.
    View in: PubMed
    Score: 0.013
  55. Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making. 1998 Jul-Sep; 18(3):278-86.
    View in: PubMed
    Score: 0.013
  56. Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):313-317.
    View in: PubMed
    Score: 0.013
  57. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
    View in: PubMed
    Score: 0.012
  58. Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan; 168(1):17-22.
    View in: PubMed
    Score: 0.012
  59. Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
    View in: PubMed
    Score: 0.012
  60. Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):237-43.
    View in: PubMed
    Score: 0.012
  61. Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology. 1997 Feb; 49(2):218-24.
    View in: PubMed
    Score: 0.011
  62. Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? Cancer Invest. 1997; 15(3):227-36.
    View in: PubMed
    Score: 0.011
  63. Western impressions of the Hong Kong health care system. West J Med. 1996 Jul-Aug; 165(1-2):37-42.
    View in: PubMed
    Score: 0.011
  64. Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years. J Oncol Pract. 2016 06; 12(6):e670-80.
    View in: PubMed
    Score: 0.011
  65. Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
    View in: PubMed
    Score: 0.011
  66. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
    View in: PubMed
    Score: 0.010
  67. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul; 26(7):1390-5.
    View in: PubMed
    Score: 0.010
  68. Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology. 1995 Apr; 45(4):633-40.
    View in: PubMed
    Score: 0.010
  69. Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep. 1995 Mar-Apr; 110(2):166-72.
    View in: PubMed
    Score: 0.010
  70. Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). 2015 Apr; 24(4):291-8.
    View in: PubMed
    Score: 0.010
  71. Informal caregivers of persons with AIDS. J Palliat Care. 1995; 11(2):10-8.
    View in: PubMed
    Score: 0.010
  72. The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):38-42.
    View in: PubMed
    Score: 0.010
  73. Racial differences in cervical cancer mortality in Chicago. Am J Public Health. 1994 Jun; 84(6):1007-9.
    View in: PubMed
    Score: 0.010
  74. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014 Mar-Apr; 12(2):121-7.
    View in: PubMed
    Score: 0.009
  75. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):134-43.
    View in: PubMed
    Score: 0.009
  76. Improving colon cancer screening in community clinics. Cancer. 2013 Nov 01; 119(21):3879-86.
    View in: PubMed
    Score: 0.009
  77. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013 Aug; 31(8):1669-75.
    View in: PubMed
    Score: 0.009
  78. Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. 2013 Jul; 53(7):773-8.
    View in: PubMed
    Score: 0.009
  79. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. 2014 Jan; 32(1):26.e25-31.
    View in: PubMed
    Score: 0.009
  80. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 2013 Jan; 81(1):130-4.
    View in: PubMed
    Score: 0.009
  81. Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1992; 5(9):856-64.
    View in: PubMed
    Score: 0.008
  82. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2012 Jul; 110(2):201-5.
    View in: PubMed
    Score: 0.008
  83. Patterns of care related to age of men with prostate cancer. Cancer. 1991 May 15; 67(10):2633-41.
    View in: PubMed
    Score: 0.008
  84. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010 Sep; 95(9):1555-62.
    View in: PubMed
    Score: 0.007
  85. Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs. J Palliat Med. 2010 Feb; 13(2):161-9.
    View in: PubMed
    Score: 0.007
  86. Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother. 2010 Apr; 54(4):1534-40.
    View in: PubMed
    Score: 0.007
  87. The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology. 2010 Mar; 75(3):623-9.
    View in: PubMed
    Score: 0.007
  88. Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack. Intern Med J. 2010 Apr; 40(4):275-80.
    View in: PubMed
    Score: 0.007
  89. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
    View in: PubMed
    Score: 0.007
  90. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008 Mar 01; 27(5):412-21.
    View in: PubMed
    Score: 0.006
  91. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov; 45(11):1026-33.
    View in: PubMed
    Score: 0.006
  92. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
    View in: PubMed
    Score: 0.006
  93. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. 2007 Jun; 137(6):545-52.
    View in: PubMed
    Score: 0.006
  94. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
    View in: PubMed
    Score: 0.006
  95. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
    View in: PubMed
    Score: 0.006
  96. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007 Feb 07; 99(3):196-205.
    View in: PubMed
    Score: 0.006
  97. Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep. 1986 Sep; 70(9):1081-4.
    View in: PubMed
    Score: 0.006
  98. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006 Aug; 21(8):847-51.
    View in: PubMed
    Score: 0.006
  99. Staging and therapy of orbital lymphomas. Cancer. 1986 Mar 15; 57(6):1204-8.
    View in: PubMed
    Score: 0.005
  100. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005 May; 79(5):1698-703.
    View in: PubMed
    Score: 0.005
  101. Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. 2005 Apr; 2(2):A11.
    View in: PubMed
    Score: 0.005
  102. Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. 2004 Dec; 3(12):1298-303.
    View in: PubMed
    Score: 0.005
  103. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
    View in: PubMed
    Score: 0.005
  104. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.005
  105. Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997. Eur J Cancer. 2003 May; 39(7):961-7.
    View in: PubMed
    Score: 0.004
  106. Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. 2003 Feb; 15(2):60-2.
    View in: PubMed
    Score: 0.004
  107. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003 Jan; 61(1):172-8.
    View in: PubMed
    Score: 0.004
  108. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002 Sep; 1(2):105-14.
    View in: PubMed
    Score: 0.004
  109. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000 Jul; 164(1):214-8.
    View in: PubMed
    Score: 0.004
  110. Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
    View in: PubMed
    Score: 0.003
  111. Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
    View in: PubMed
    Score: 0.003
  112. QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Williston Park). 1999 Jun; 13(6):823-32; discussion 835-8.
    View in: PubMed
    Score: 0.003
  113. Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol. 1998 Dec; 71(3):369-75.
    View in: PubMed
    Score: 0.003
  114. Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc. 1998 Jan; 73(1):5-9.
    View in: PubMed
    Score: 0.003
  115. Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997 Sep; 50(3):366-72.
    View in: PubMed
    Score: 0.003
  116. AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med. 1996 Oct; 11(10):591-6.
    View in: PubMed
    Score: 0.003
  117. Evaluation of two AIDS education programs for impoverished Latina women. AIDS Educ Prev. 1994 Aug; 6(4):296-309.
    View in: PubMed
    Score: 0.002
  118. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):1043-50.
    View in: PubMed
    Score: 0.002
  119. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1993 Jun; 6(6):617-23.
    View in: PubMed
    Score: 0.002
  120. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease. Anticancer Drugs. 1993 May; 4 Suppl 1:13-6.
    View in: PubMed
    Score: 0.002
  121. AIDS-related knowledge, perceptions, and behaviors among impoverished minority women. Am J Public Health. 1993 Jan; 83(1):65-71.
    View in: PubMed
    Score: 0.002
  122. Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach. J Clin Epidemiol. 1989; 42(5):421-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.